par Manicourt, Daniel ;Orloff, Serge
Référence The New England journal of medicine, 302, 12, page (696)
Publication Publié, 1980-03
Lettre à l'éditeur
Résumé : To the Editor: In view of our interest in serum levels of β2-microglobulin as a measure of activity in autoimmune disease,1 , 2 we would like to comment on the discrepancies between the data of Descos et al.3 and Kruis et al.4 on β2-microglobulin levels in Crohn's disease. We studied serum levels and urinary excretion of β2-microglobulin (Phadebas RIA Kits) in 23 patients with Crohn's disease. Patients were 27 to 56 years of age, and none had received corticoids, azathioprine, or levamisole. Six had ileitis, 12 ileocolitis, and five colitis. According to Best's criteria,5 the disease. © 1980, Massachusetts Medical Society. All rights reserved.